STA-9090(Ganetespib) in Metastatic Ocular Melanoma
NCT01200238
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
17
Enrollment
OTHER
Sponsor class
Conditions
Ocular Melanoma
Interventions
DRUG:
STA-9090
Sponsor
Dana-Farber Cancer Institute
Collaborators
[object Object]
[object Object]
[object Object]
[object Object]